Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q2-2019 Ophthalmology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q2-2019 Ophthalmology Update

Ophthalmology continues to be at the forefront of consolidation activity within physician services, with two more private equity firms investing in the sector in the second quarter of 2019. Over two dozen groups have taken on institutional capital over the last two and a half years, and with the concept of private equity gaining more traction within the ophthalmology community, transaction volume is expected to remain at elevated levels throughout the second half of the year and into the foreseeable future. As the market continues to evolve and mature, Provident expects to start to see the more established private-equity backed platforms trade hands with larger private equity groups looking to invest in the highly sought after sector with the potential of mergers among private equity-backed consolidators.​

To print and download the full Ophthalmology Update report, please click below…

[holo_button icon=”” link=”/wp-content/uploads/2019/07/Q2-2019-Ophthalmology-Newsletter.pdf” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]

 

Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.